Skip to content or footer

The Company

Scotmas is a leading manufacturer of water treatment, hygiene and environmental care products. Best known for its extensive range of chlorine dioxide systems, developed with over 25 years experience in the market, it is now actively involved in developing microbial biotechnology, insect repellents, insecticidal textiles and consumer product ingredients.

With a strong and continued commitment to R&D, Scotmas is always on the look-out for strategic investment opportunities with other companies and projects which can provide experience and capabilities that will add value to its offering.

The Business Challenge

An introduction to Interface – The knowledge connection for business, presented an opportunity to advance two research projects, one looking at bacteria identification and another on bacteria and virus tests. Following an extensive search of expertise in the field, Interface helped the company to develop active partnerships with several academic institutions.

The company produces microbe-based products used for a variety of applications in waste water treatment and land remediation, but wanted to expand this into a range of domestic cleaners and products for specific industrial contamination.

The Solution

Following discussions with the University of Aberdeen, it was learnt that spin out company NCIMB was undertaking the characterisation of the bacteria strains on a routine basis.

Scotmas was looking for help to investigate the effectiveness of one of its products for a client. Interface facilitated a project with Glasgow Caledonian University’s Dr Chris Woodall, from the School of Life Sciences, offering specialist testing services for bacteriological and viral testing. The project resulted in a continued relationship and subsequent testing work.

Following the success of the initial project, Scotmas embarked on a number of new collaborative projects, including corrosion studies and a project on microencapsulation and was in active discussions with other academic groups including Scottish Crop Research Institute and the University of Glasgow.

Benefits

Alistair Cameron, Technical Director at Scotmas commented:

“We were looking to strengthen our range of microbe-based products in a variety of domestic cleaners and products for tackling specific industrial contamination.  Interface linked us to academic partners who helped in the commercial culturing of these microbes, in order to supply a powdered product to Scotmas’s commercial operations.”

Scotmas went on to collaborate with the engineering department at Heriot Watt University, an academic team that were included in the University’s research submission to REF 2014* (Research Excellence Framework), 94% of which was judged as “world-leading” or internationally excellent. 

In November 2016 Scotmas announced that they are sending new self-sustaining technology to Botswana to bring properly treated water supplies to some of its most remote areas.The Bravo Hydro system runs without grid electricity or solar power, using a tiny generator in the water pipe. Scotmas said the technology could bring reliably disinfected water to areas where it had not been possible before.It is being sent to 40 villages in Botswana thanks to a major investment by the country’s government. ​

Scotmas undertook around ten collaborative projects with academia since the original project facilitated by Interface including two Knowledge Transfer Partnerships (KTPs) with Heriot-Watt University. The family business employs 42 people and provides chlorine dioxide water solutions around the world – including in Doha for the Qatar World Cup 2022 and in villages in southern India.

In 2020 Interface linked Scotmas to Robert Gordon University to support the development of a new and innovative method of producing disinfectants without harmful by-products for use in hospitals, water supplies and food production applications. The project was funded through an Advanced Innovation Voucher and won Innovation of the Year at The Scottsh Knowledge Exchange Awards 2021.

*The REF is the system for assessing the quality of research in UK higher education institutions.

Background

Headquartered in Glenbervie near Stonehaven, Scotland, Macphie is the UK’s leading, independent, added-value food ingredients manufacturer, and has been producing premium quality food ingredients and solutions for customers across 40 countries for over 85 years.

Challenge

The company approached Interface to seek help in finding relevant academic collaborators to provide solutions to a range of challenges facing their business. These ranged from reducing saturated fat content and creating “cleaner label” products to rethinking their packaging and storage.
 

Solution

Interface has facilitated a series of collaborative projects with numerous Scottish Universities to support the business challenges.

Project areas have included:

To date, Macphie has been involved in more than 15 individual collaborative research projects with multiple universities which have yielded cost savings to the business of many hundreds of thousands of pounds.
 

Business benefits

“Innovation is a cornerstone for Macphie, developing new technologies, products, processes and packaging to add value to our business and better meet our customer needs.

Macphie utilises Interface as a Scottish brokering service that brings businesses and universities together. Interface has facilitated a series of collaborative projects across a range of business requirements with Scottish universities. Using the Interface network, we have managed to completely accelerate our innovation agenda.

At Macphie we now have a rich heritage of academic projects across many aspects of our business. These translate into shaping and driving our innovation agenda. Interface is a crucial partner in enabling us to pair up with the very best academic organisations to achieve success. Our ongoing outlook is to continue to invest resources in long-term, transformational projects to ultimately add even greater value to our customer offering.” Martin Ruck, Macphie’s Head of Research and Development.

Academic benefits

Following a successful masters project with Abertay University on computer and web Enabled Food Product Evaluation System:

“Abertay has a specific interest in pursuing links with industry as part of the University’s Strategic Plan. The work with Macphie is an excellent example of how Abertay can be recognised for developing graduates equipped with the attributes and attitudes to contribute significantly to future economies. 

The work has also been conducive for developing pathways to impact, allowing Abertay to generate an excellent track record with respect to KE activities that generate further income and reputation for the University.”  Dr Nia White, Head of the Graduate School, Abertay University.

Interface also supported Macphie and the University of Edinburgh to develop and test a series of emulsions to use in a commercial setting. This led on to further studies on the role of fat crystallisation in the process of stabilizing emulsions and foams which enabled the company to increase the unsaturated fats in their products.

“It was very interesting for us to apply our expertise in the physics of emulsion technology to support a company developing healthier products.”
Dr Tiffany Wood, Director of the Edinburgh Complex Fluids Partnership, The University of Edinburgh.

Additional notes

Macphie have worked with the following Universities and Research Institutes: University of Edinburgh, Glasgow Caledonian University, University of Strathclyde, Heriot-Watt University, Rowett Institute of Nutrition and Health at the University of Aberdeen, Robert Gordon University, Abertay University, Queen Margaret University.

Adrok Ltd is an award winning technology developer and provider of unique imaging and mapping solutions based on proprietary technology known as the Atomic Dielectric Resonance (ADR) Scanner.

The technology has been developed by Adrok’s founder and science director, Colin Stove, who has been successfully imaging ground targets from space for the UK government, the European space Agency, NASA and commercial organisations for over forty years.

This scanner has the ability to identify and image any substance down to molecular or atomic level. Adrok’s patented technology works by sending a narrow beam of energy into the ground using micro and radio waves and allows the depth penetration of this energy to be much greater than conventional methods.

There are two main markets where Adrok focuses its commercialisation efforts to apply its technology developments; Subsurface earth imaging (Geological) and Medical markets.

In the Geological market, ADR is applied to provide meaningful images of unique material classifications of the structure and the content of the earth’s subsurface (hydrocarbons, precious minerals, water).

The Business Challenge

Gordon Stove, Adrok managing director, said: “The contribution our technology can make is multifaceted. Very little of the Earth’s subsurface has been mapped to date and the potential of ADR technology could significantly improve this situation in terms of delivering dielectric readings of up to 80km below the surface, at a far faster and more economical rate than has previously been possible.”

The Earth’s crust is currently mapped through seismic technology, which measures the elastic property of rocks and is expensive in terms of time and equipment. The company sought academic expertise to develop a two dimensional ADR bore hole image to determine dielectric rock properties at depths that will help them understand the deeper tectonic processes that can cause earthquakes and other natural events.

The Solution
The firm was introduced to Dr Randell Stephenson, Reader in Geophysics at the University of Aberdeen through Interface – The knowledge connection for business, which helps partner some of the country’s most innovative companies with leading academics.

The geophysicists worked with Adrok to see whether the firm’s existing one-dimensional virtual borehole system could be developed to generate two-dimensional subsurface profile images.

After preliminary analyses funded through a Scottish Funding Council Innovation Voucher, Dr Stephenson comments: “We need to conduct further analysis to determine the full resolution potential of ADR technology; however, if a two dimensional subsurface geological image can be achieved at depths of tens of kilometres, we will have a novel way of complementing existing information and potentially a far deeper understanding of the tectonic processes that produce the geology we see at the Earth’s surface.”

The approach represents a major advance in physics with a competitive advantage for additional industries including minerals, water, life sciences, civil engineering, defence, security and industrial quality control.

Canon Medical Research Europe Ltd (previously Toshiba Medical Visualization Systems Europe Ltd) in Edinburgh is a key part of Canon Medical Systems Corporation’s global R&D network and is responsible for the design and development of cutting edge products and technology for use in medical imaging equipment.

The Business Challenge
 

Keen to tap into the expertise available within academia, Canon Medical Research Europe Ltd became aware of Interface at an event and arranged further meetings to discuss the company’s research and development requirements.

A specification was agreed and Interface undertook an expertise search for potential academic collaborators.

Ian Poole, Senior Scientist commented, “Interface offers companies access to a diverse network of world class expertise and plays a vital role in facilitating the partnerships.”

Interface identified the knowledge and facilities required within the SINAPSE POOL.
SINAPSE, the Scottish imaging network, is at the forefront of research in the field of brain imaging and brings together six of Scotland’s top universities – Aberdeen, Dundee, Edinburgh, Glasgow, St Andrews and Stirling.

Canon Medical Research Europe Ltd recognised the opportunity to capitalise on the extensive expertise within SINAPSE and was keen work with the group.

The Solution

Interface worked with SINAPSE and Canon Medical Research Europe Ltd to develop a successful Staff Exchange Programme with the University of Edinburgh and the University of Aberdeen.

Both parties have experienced significant benefits from this collaboration. The programme is a true example of successful knowledge exchange between academia which involves Canon Medical Research Europe Ltd employees spending time in a clinical environment and SINAPSE researchers and students spending time at the company premises embedded in an industrial environment.

Canon Medical Research Europe Ltd were able to explore with researchers the different technologies, techniques and approaches which can be used to develop images that may result in new or improved clinical diagnosis. The programme also provides university researchers with the opportunity to see how their research can be transformed into marketable products within an industry environment, building awareness of the tough requirements involved with commercial software. In addition the programme acts as a catalyst for innovation within Canon Medical Research Europe Ltd in providing an environment which is conducive to exploring new ideas.

Two Engineering Students at the University of Edinburgh also undertook placement at Canon Medical Research Europe Ltd.

The Future

The initial partnership between SINAPSE and Canon Medical Research Europe Ltd continues to flourish and has led to discussions regarding a larger collaboration which will build on the current project. The company has also announced its decision to launch a major new R&D programme in healthcare imaging informatics at its Edinburgh facility.

Ken Sutherland, Director of R&D at Canon Medical Research Europe Ltd’s Edinburgh facility commented, “Its great that we can tap into some of the first class academic research going on here in Scotland and at the same time play a useful role by sifting and highlighting those aspects of research that look most promising in terms of commercially viable innovation”.

Dr. Siobhán Jordan, Director at Interface commented, “The Staff Exchange Programme further demonstrates the importance and potential benefits of business and academia working in partnership. I am sure the recent news announced by Canon Medical Research Europe Ltd will present future potential collaborative opportunities between the two networks.”